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Post-transplant hypertension in the rat: Effects of captopril and native
nephrectomy. In patients with well-functioning renal allografts, the
presence of diseased native kidneys appears to be a common cause of
elevated blood pressure. We evaluated the role of native kidneys in
post-transplant hypertension using a rat model in which the confound-
ing variables of rejection and immunosuppression could be eliminated.
To produce disease in native kidneys, PVG rats were subjected to 5/6
nephrectomy. Four weeks following renal ablation, these hypertensive
animals were transplanted with kidneys from syngeneic PVG donors.
Four weeks later, the effects of captopril and native nephrectomy on
blood pressure and renal hemodynamics were examined. Animals with
remnant native kidneys which received non-rejecting renal isografts had
sustained hypertension, elevated plasma renin levels and reduced
transplant function. In these animals, administration of captopril re-
duced systemic blood pressure. Despite the reduction in blood pres-
sure, PAH clearance by the transplanted kidney increased markedly
while GFR rose modestly. Removal of the remnant native kidney also
acutely lowered blood pressure. However, compared to captopril,
native nephrectomy produced a more marked increase in GFR without
significantly affecting renal blood flow. In this model of post-transplant
hypertension in the rat, elevated blood pressure and reduced isograft
function are mediated by the diseased native kidney, in part through the
effects of angiotensin II. These data suggest that ACE inhibitors and
native nephrectomy may have beneficial hemodynamic effects in pa-
tients with post-transplant hypertension caused by native kidneys.
Hypertension complicating successful renal transplantation is
a significant clinical problem [1]. The prevalence of hyperten-
sion in patients with functioning renal allografts has been
reported to be as high as 50 to 60% [2, 3]. However, the etiology
of elevated blood pressure in these patients is often difficult to
determine. Causes of hypertension in renal transplant recipients
include: reduced renal function secondary to rejection [4],
transplant renal artery stenosis [51, and side effects of immuno-
suppressive agents, such as corticosteroids or cyclosporine [61.
In addition, in a significant number of patients, hypertension
seems to be related to the presence of diseased native kidneys
[7, 8].
Clinical identification of patients with elevations of blood
pressure caused by native kidneys is difficult. In this regard,
Curtis and associates have hypothesized that patients with
hypertension caused by diseased native kidneys may be iden-
tified through their renal hemodynamic response to angiotensin
converting enzyme (ACE) inhibition [9]. Their studies suggest
that an increase in effective renal plasma flow in the transplant
kidney following a single dose of captopril may be characteristic
of hypertension dependent on native kidneys. However, the
specificity and mechanisms underlying this response are not
clear. Furthermore, mechanisms through which diseased native
kidneys might cause post-transplant hypertension are not well
defined.
To address this issue, we developed an animal model to
evaluate the role of native kidneys in post-transplant hyperten-
sion independent of the confounding variables of rejection and
immunosuppressive therapy. In this non-rejecting renal isograft
model, we compared the effects of captopril and native ne-
phrectomy on blood pressure and renal hemodynamic function.
Methods
Animals
Inbred male rats of the PVG (RT1C) strain were used in these
studies. These animals were initially obtained from OLAC Ltd.
(Bicester, UK) and have been maintained and bred in the
animal colony of Dr. Fred Sanfilippo. Rats were fed standard
laboratory chow and allowed free access to food and water
throughout the study.
Preparation of recipients
To produce disease in native kidneys, inbred PVG rats were
subjected to 5/6 nephrectomy. After animals were anesthetized
with halothane, the abdomen was opened and the right renal
pedicle was isolated, ligated distal to the adrenal artery, and the
entire right kidney was removed. The branches of the left renal
artery were then isolated and two of the three branches were
ligated with 4'O silk suture. Following surgery, animals were
given a single dose of aqueous penicillin G (15,000 U/kg). Four
weeks following renal ablation, animals were transplanted with
kidneys from normotensive, syngeneic PVG donors. In addi-
tion, a group of animals underwent 5/6 nephrectomy but were
not transplanted. In this control group, blood pressure and renal
hemodynamics were measured eight weeks after renal ablation.
Renal transplants
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Rat renal transplants were performed as previously described
[10] using a modification of the technique of Fabre, Lim and
Morris [11]. Recipients were PVG rats which had undergone
renal ablation four weeks earlier as described above. Donors
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were genetically identical normotensive PVG strain rats. The
donor kidney, ureter and bladder were harvested en bloc,
including the renal artery with a 3 mm aortic cuff and the renal
vein with a 3 mm vena caval cuff. Anastomoses were created
between these vascular cuffs and the recipient abdominal aorta
and vena cava, respectively. Total ischemic time averaged 35 to
40 minutes. Donor and recipient bladders were attached dome
to dome. Following surgery, animals were given a single dose of
aqueous penicillin G (15,000 U/kg).
Transplanted animals were divided into two groups. Group I
animals (N = 11) underwent left native nephrectomy through a
flank incision, 48 hours following transplantation. In Group II
animals (N = 21), a sham native nephrectomy was performed 48
hours following transplantation. Thus, in Group II animals the
native, remnant kidney was left in place. Surgical mortality was
less than 20% and was not different between Group I atid Group
II. Animals which did not survive the entire eight-week study
period were excluded from analysis. In addition, a single animal
from Group II was excluded because the transplanted kidney
was found to be hydronephrotic and non-functional at the time
of hemodynamic study.
Bloodpressure measurement
Systolic blood pressure was measured in all animals every
week with a rat tail manometer (Peninsula Labs., Belmont,
California, USA) using an indirect photosensing technique.
In vivo hemodynamic studies
On the day of study, animals were anesthetized with pento-
barbital (40 mg/kg) and a polyethylene catheter (PE-240) was
inserted into the trachea to facilitate spontaneous respiration.
The left carotid artery was cannulated to permit periodic
sampling of arterial blood and to measure arterial blood pres-
sure. During the clearance studies, mean arterial pressure
(MAP) was measured using a Statham strain gauge and a
Hewlett-Packard carrier pre-amplifier (8805B) and recorder
(7702B). The jugular vein was cannulated and, after infusion of
a volume of normal saline equal to 1% of body weight to replace
surgical losses, carboxyl-'4C-inulin and glycyl-3H-PAH (New
England Nuclear, Boston, Massachusetts, USA) in normal
saline were infused at a rate of 25 l/100 g/min. In some
animals, the left renal vein was catheterized with a curved 0.965
mm OD teflon catheter inserted through the left femoral vein in
order to collect samples for the determination of renal venOus
PAH concentrations. Ureters were cannulated with PE-lO
catheters.
After a 45-minute equilibration period, MAP and baseline
clearances of inulin (C1) and p-aminohippuric acid (CPAH) were
measured during two 30-minute urine collections. Arterial
blood samples were obtained at the midpoint of each collection.
Renal venous blood samples were also obtained so that renal
PAH extraction (EPAH) could be determined. Renal blood flow
(RBF) was then calculated by the formula:
RBF = CPAH/[EPAH (1 — Hct)j.
Following the control clearances, 10 mg/kg of captopril was
administered by i.v. bolus. After a 30-minute equilibration
period, MAP, C1, CPAH and RBF were measured during two
additional thirty-minute urine collections. As a time control,
some of the Group II animals (N = 4) received vehicle instead
of captopril.
In an additional subset of Group II animals (N = 5), the acute
effects of native nephrectomy on renal hemodynamics and
blood pressure were determined. Four weeks following trans-
plantation, clearance studies were performed. Following the
two 30-minute control clearances, the pedicle of the left native
kidney was double ligated and the kidney was removed. After a
30-minute equilibration period, C1, CPAH and RBF were again
measured during two 30-minute urine collections.
Plasma renin activity
Four weeks following transplantation, plasma renin activity
(PRA) was determined in animals from Groups I (N = 6) and II(N = 8). For comparison, PRA was measured in a group of
normal PVG rats (N = 5) and a group of rats which had
undergone 5/6 nephrectomy alone (N = 7). Plasma samples
were obtained from unanesthetized animals following decapita-
tion and were stored at —20°C. These specimens were later
thawed at 4°C and diluted with maleate buffer in the presence of
diinercaprol and 8-hydroxyquinoline. Samples were then incu-
bated at 37°C and concentration of angiotensin I was deter-
mined by radioimmunoassay. Plasma renin activity is expressed
as ng/ml/hr of angiotensin I.
Statistics
Data are presented as the mean standard error of the mean.
In the hemodynamic studies, individual values for each animal
represent the mean of values measured during two clearance
periods or sample collections. Statistical significance within
groups was assessed using a paired t-test. For comparisons
between Group I and Group II, an unpaired t-test was used. For
comparisons between more than two groups, statistical analysis
was performed by one-way analysis of variance followed by
Bonferroni's procedure for multiple pairwise comparisons [121.
Results
Figure 1 depicts systolic blood pressure in PVG recipient
animals versus time. Five-sixths nephrectomy produced a sig-
nificant increase in systolic blood pressure from 118 5 before
renal ablation to 144 5 mm Hg (P < 0.005) one week following
surgery. This level of blood pressure elevation was sustained
during the four weeks prior to transplantation. Following trans-
plantation and removal of the remnant native kidney, systolic
blood pressure decreased significantly in Group I animals from
161 5 to 136 8 mm Hg (P < 0.01). In contrast, transplan-
tation with a well-functioning isograft did not significantly lower
blood pressure in the Group II (sham native nephrectomy)
animals. Thus, four weeks after transplantation, systolic blood
pressure was significantly increased in Group II animals (163
5 mm Hg) compared to Group 1(136 5 mm Hg; P < 0.005).
However, in animals which had undergone 5/6 nephrectomy but
were never transplanted, blood pressure had increased to 203
10 mm Hg by eight weeks following renal ablation (P < 0.005
vs. Group II).
Clearances of inulin and PAH by transplanted kidneys in
Group I and Group II animals are depicted in Figure 2. At the
time of these hemodynamic studies, there was no significant
difference in body weight between Group I (286 8 g) and
Group 11(306 9 g). Inulin clearance by renal isografts in
hypertensive Group II animals (3.08 0.47 mI/mm/kg) was
significantly lower than Group I animals (5.64 0.45 mI/mm/kg;
P < 0.005) which had undergone native nephrectomy at the
time of transplantation. Similarly, PAH clearance by trans-
planted kidneys from Group II animals (8.24 1.37 mI/mm/kg)
was reduced compared to Group 1(16.33 0.61 mI/mm/kg; P <
0.005). However, there was no significant difference in renal
extraction of PAH between the two groups (62 6% vs. 72
5%). Thus, renal isograft function was impaired significantly in
animals with post-transplant hypertension (Group II) compared
to controls (Group I). Interestingly, in Group H, values for
whole animal (transplant + remnant native kidney) clearances
of inulin (4.39 0.53 mI/mm/kg) and PAH (11.60 1.42) were
not significantly different from that of animals which underwent
5/6 nephrectomy without transplantation (4.36 0.24and 11.18
1.76 mI/mm/kg).
Figure 3 demonstrates the acute effect of converting enzyme
inhibition with captopril (10 mg/kg) on mean arterial pressure in
rats with post-transplant hypertension (Group II). Mean arterial
pressure in anesthetized animals during the control period was
significantly elevated in Group II animals (147 6 mm Hg)
compared to Group I controls (113 7 mm Hg; P < 0.005). As
seen in Figure 3, administration of captopril resulted in a
significant fall in mean arterial pressure in Group II animals
from 147 6 to 122 8 mm Hg (P < 0.01). Captopril had no
significant effect on blood pressure in Group I controls (113 7
vs. 106 6 mm Hg).
The acute effects of captopril on renal isograft function in rats
with post-transplant hypertension (Group II) are depicted in
Figure 4. Despite a significant reduction in systemic blood
pressure, administration of captopril resulted in a marked and
significant increase in PAH clearance by the transplanted
kidney from 8.24 1.37 to 13.48 0.98 mI/mm/kg (P < 0.005),
but did not significantly affect renal PAH extraction. Renal
blood flow also increased from 12.37 6.03 to 31.86 9.90 ml!
mm/kg following captopril. In addition, captopril produced a
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Fig. 1. Effects of renal ablation (5/6
nephrectomy), isogeneic transplantation and
native nephrectomy on systolic blood pressure
in conscious rats. The black circles represent
blood pressure values for recipient animals
during the four weeks prior to transplantation.
Symbols are: (0) animals which underwent
native nephrectomy at the time of
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—3 —2 —1 0 1 2 3 4 transplantation (Group I); (•) animals whichhad sham native nephrectomy (Group II). *J1
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Fig. 2. Hemodynamic function of transplanted kidneys in animals
from (Q) Groups I and (0) II. < 0.005 vs. Group 1. I I
Control Captopril
10mg/kg
Fig. 3. Effect of captopril on mean arterial pressure in rats with
post-transplant hypertension (Group II). < 0.01 vs. control.
Table 1. Effect of acute native nephrectomy on BP and renal
function of rats with post-transplant hypertension (Group H)
P
Control Post-NX value
MAP 152 9 122 10 <0.005
mm Hg
GFR 3.59 0.44 5.19 0.33 <0.01
mi/mm/kg
CPAH 8.51 1.28 10.52 1.85 NS
mi/mm/kg
modest increase in GFR from 3.08 0.47 to 3.99 0.20 ml/min/
kg (P < 0.05) in the animals with post-transplant hypertension
(Group II). In contrast, captopril did not significantly alter renal
isograft function in Group I. In these control animals, CPAH
(15.79 0.73 vs. 17.56 1.87 mI/mm/kg), GFR (5.42 0.45 vs.
5.72 0.35 rnL/minlkg) and RBF (39.26 3.47 vs. 44.37 mI/min/
kg) were not significantly affected by captopril administration.
In time controls which received vehicle instead of captopril,
there was no significant change in isograft GFR (3.72 0.83 vs.
3.53 1.05 ml/min/kg), CPAH (7.97 1.56 vs. 7.95 1.98 ml!
mm/kg) or MAP (170 9 vs. 165 12 mm Hg) over an identical
study period.
In a separate set of Group II animals, we examined the acute
effects of removing the remnant native kidney upon blood
pressure and renal transplant function. The effects of native
nephrectomy done four weeks following transplantation are
shown in Table 1. Similar to captopril, native nephrectomy
resulted in a significant fall in mean arterial pressure from 152
9 to 122 10 mm Hg (P < 0.005). However, nephrectomy
affected renal function somewhat differently than captopril.
Native nephrectomy produced a more marked increase in GFR
in the transplanted kidney from 3.59 0.44 to 5.19 0.33 ml!
mm/kg (P < 0.01). In contrast to the effect to captopril, removal
of the native remnant kidney did not significantly affect PAH
clearance by the isograft (8.51 0.97 vs. 10.52 1.45 mI/mm!
kg).
Plasma renin activity (PRA) in the experimental groups is
shown in Figure 5. In Group II animals, plasma renin activity
was significantly elevated (5.84 0.47 ng/ml!hr) compared to
Group 1(2.62 0.46 ng/mllhr; P < 0.0005) or non-transplanted
normal controls (3.20 0.56 ng!ml/hr; P < 0.005). In addition,
PRA in Group II animals was not significantly different from
animals which had undergone 5/6 nephrectomy without trans-
plantation (6.75 1.48 ng/ml/hr).
Discussion
Hypertension related to the presence of diseased native
kidneys is common in patients with well-functioning renal
allografts [81. The importance of native kidneys in producing
hypertension is supported by the observation that pre-trans-
plant native nephrectomy is associated with a significant reduc-
tion in the prevalence of hypertension following successful
transplantation [3, 13]. Furthermore, in selected hypertensive
patients, native nephrectomy following transplantation can be
extremely effective in reducing blood pressure [14, 15].
In the present study, we developed a rat model of native
kidney dependent, post-transplant hypertension. We found that
animals with remnant native kidneys which received non-
rejecting renal isografts had sustained hypertension and re-
duced transplant function. In these animals with post-transplant
hypertension, administration of captopril reduced systemic
blood pressure. Following captopril, PAH clearance and renal
blood flow increased markedly in the transplanted kidney, while
GFR rose only modestly. Removal of the remnant native kidney
also acutely lowered blood pressure. However, compared to
captopril, native nephrectomy produced a more marked in-
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Fig. 4. Effects of captopril on renal transplant
function in rats with post-transplant hypertension
Captopril (Group H). **P < 0.005 vs. control; < 0.05 vs.
10mg/kg control.Control Captopril10mg/kg
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Fig. 5. Plasma renin activity in unanesthetized rats. Symbols are: (D)
Group I; () Group H. *P < 0.0005 vs. Group I.
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crease in GFR without significantly affecting PAH clearance or
renal blood flow. Plasma renin activity remained elevated in
animals with post-transplant hypertension compared to controls
and was not different from animals which had undergone 5/6
nephrectomy without transplantation.
We have previously shown that native kidneys can have
profound effects on sodium excretion and recovery from isch-
emic injury following transplantation [16]. The studies de-
scribed here further emphasize the potentially important role of
diseased native kidneys in directly influencing renal transplant
function and blood pressure. Our studies also support the
clinical observations of Curtis and associates [9] which suggest
that renal hemodynamic response to captopril may identify
patients with native kidney dependent hypertension. However,
a recent preliminary report from their group has suggested that
these hemodynamic effects may be altered in patients taking
cyclosporine [17]. Thus, while the specificity of this response in
the presence of various immunosuppressive regimens and re-
jection is not known, the model which we have developed
provides a setting in which the effects of these factors could be
systematically examined.
Other animal models of post-transplant hypertension have
been described previously. For example, de Keijzer et al have
developed a rat model of immunologically enhanced allografts
which exhibit post-transplant hypertension [181. In these ani-
mals, the native kidneys were removed and transplant GFR was
substantially reduced. Renal histomorphology was also abnor-
mal and suggested ongoing rejection. This model may be most
analogous to hypertension associated with chronic rejection
and reduced allograft function. McDougall et al described
another model of post-transplant hypertension in sheep [19]. A
native kidney was transplanted heterotopically into the neck
and hypertension was produced by constricting the transplant
renal artery. Functionally, this model is similar to transplant
renal artery stenosis. However, neither of these studies exam-
ined the contribution of native kidneys to the development of
hypertension.
The mechanisms by which native kidneys cause clinical
blood pressure elevation have not been well defined. In some
patients, increased renin secretion by diseased native kidneys
can be demonstrated [7j. In contrast, other patients without
evidence of elevated renin production may experience a reduc-
tion in blood pressure following native nephrectomy [14, 15].
Our studies support a role for the renin-angiotensin axis in
native kidney dependent hypertension. In our experimental
model, the elevation in plasma renin activity and the dramatic
response to captopril suggest that hypertension, as well as
reduced isograft function, may be mediated in part by angio-
tensin II. However, the differences in response to captopril
compared to acute nephrectomy suggest that other mechanisms
may also be important. Alterations in the kallikrein-kinin sys-
tem [20, 21] or production of arachidonic acid metabolites [10]
have been considered to be important in post-transplant hemo-
dynamics and might play a role in this process.
Pretranspiant native nephrectomy was once a routine proce-
dure. However, because of appropriate concerns about the
detrimental effects of native nephrectomy for patients who lose
their transplants and return to dialysis [22—24], this procedure
has been largely abandoned. More recently, native nephrec-
tomy as treatment for hypertension in selected patients has
been advocated [25]. Our data clearly demonstrate the poten-
tially dramatic effects of diseased native kidneys on both blood
pressure and long-term graft function. Although the relevance
of these findings to clinical transplantation is not clear, many of
the characteristics of this model, such as the hemodynamic
response to captopril, mimic native kidney dependent hyper-
tension in humans. While our data provide theoretic rationale
for the use of native nephrectomy and ACE inhibitors in the
treatment of post-transplant hypertension, specific criteria for
identification of patients with native kidney dependent hyper-
tension, as well as information about the long term impact of
treatment are necessary before these modalities can be more
generally applied.
In summary, we have developed an experimental model of
post-transplant hypertension dependent on native kidneys. In
this model, the presence of an abnormal native kidney is
associated with elevated blood pressure and reduced renal
transplant function. Hypertension and abnormal renal hemody-
namics are mediated by the native kidney, in part, through the
effects of angiotensin II. These data suggest that ACE inhibitors
and native nephrectomy may have beneficial hemodynamic
effects in patients with post-transplant hypertension caused by
native kidneys.
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